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The aim of this study was to determine the age at onset of 
psoriasis in a population-based twin sample. Questionn-
aire-data in 10,725 twin pairs, 20–71 years of age, from 
the Danish Twin Registry, was collected, and analysed 
using survival regression analysis. Median age at onset 
was 25 and 28 years among women and men, respecti-
vely. The correlation between the ages was 0.84 (boots-
trap standard error = 0.044) in monozygotic twin pairs 
and 0.60 (0.051) in dizygotic twin pairs, permutation 
p = 0.001. Age at onset of psoriasis in the index twin did 
not predict risk of psoriasis in the co-twin, hazard ratio 
(per year of later onset = 1.01 (0.99–1.03), p = 0.434. In 
conclusion, these data support that the age at onset of 
psoriasis is, in part, an inherited property. Our results 
do not support that early-onset psoriasis is more gene-
tically determined. Key words: Age at onset; psoriasis; 
twins; twin study; genetic.
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Psoriasis is a chronic inflammatory disease characterized 
by uncontrolled proliferation of keratinocytes, activated 
dendritic cells, release of proinflammatory cytokines and 
recruitment of T cells into the skin (1, 2). Psoriasis af-
fects approximately 2–3% of all Caucasians (3, 4). The 
first skin manifestations can occur at any age; however, 
2 peaks in age at onset have been described, the first at 
approximately 16 years of age (in females) or 22 years 
of age (in males), and the second at approximately 60 
years of age (in females) or 57 years of age (in males). 
Approximately 75% of patients develop the disease 
before the age of 40 years (5, 6).
The 2 peaks in age at onset have given rise to the 
hypothesis that 2 forms of the disease exist: psoriasis of 
early-onset, which is likely to be familial, and psoriasis 
of late-onset, which is more likely to be sporadic and 
non-familial. Family studies have indicated that age 
at onset is an inherited property (5, 7–9). This is also 
supported by genetic studies, which have shown that 
early-onset psoriasis is associated with variation in 
the human lymphocyte antigen (HLA), whereas late-
onset psoriasis has only a weak association with HLA 
(5, 10, 11).
A few twin studies have investigated age at onset of 
psoriasis (12–17). However, this was not the primary 
objective of these studies and most of them examined 
an insufficient number of twins. Consequently, the aim 
of this study was to examine age at onset of psoriasis in 
a large twin sample. Specifically, we used data from the 
Danish Twin Registry on physician-diagnosed psoriasis 
in 34,781 twin subjects in order to study familial cor-
relation in age at onset of psoriasis.
METHODS
Population
The studied sample comprised twins born between 1931 and 
1982 who were registered in the nationwide Danish Twin 
Registry. We have previously reported recurrence risks and 
heritability of psoriasis for this population (18). The population 
constituted 2 separate cohorts of twins, ascertained differently 
by the registry (19–21). The first cohort included twins born 
between 1931 and 1952. This cohort was identified and enrol-
led in the Danish twin registry in 1996 and corresponded to 
69% of all twin pairs born in Denmark during these years. The 
second cohort included twins born between 1953 and 1982. 
This cohort was identified and enrolled in the Danish Twin 
Registry in 1991 and corresponded to 74% of all twin pairs 
born in Denmark between 1953 and 1967 and 97% of all twin 
pairs born in Denmark between 1968 and 1982.
In 2002, these cohorts participated in a multidisciplinary 
questionnaire study concerning health and lifestyle including 
questions on psoriasis. A history of psoriasis was defined as an 
affirmative response to the question: “Has a doctor ever told 
you that you have, or have had psoriasis?” In addition to this 
question study participants were asked to report the age at which 
their disease occurred first; this information defined the age at 
onset of psoriasis. Twin zygosity was determined using 4 ques-
tions of similarity and mistaken identity, which assign zygosity 
correctly in more than 95% of cases (22). The 2 cohorts were 
20–49 and 50–71 years of age, respectively, when answering the 
questionnaire. The response rate to the questionnaire was 75%.
Genetic Factors Explain Variation in the Age at Onset of Psoriasis: 
A Population-based Twin Study
Ann Sophie LØNNBERG1, Lone SKOV1, David Lorenzo DUFFY2, Axel SKYTTHE3, Kirsten Ohm KYVIK4, Ole Birger PEDER-
SEN5 and Simon Francis THOMSEN1
1Department of Dermato-Allergology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark, 2Queensland Institute of Medical Research, Brisbane, 
Australia, 3The Danish Twin Registry, University of Southern Denmark, 4Institute of Regional Health Services Research, University of Southern Denmark, 
Odense, Denmark and Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, and 5Department of Clinical Immunology, 
Naestved Hospital, Naestved, Denmark
36 A. S. Lønnberg et al.
Statistical analysis
A Cox proportional hazards regression model was fitted with 
the time to onset of psoriasis in the co-twin of an affected twin 
(the index twin) as the underlying time, and with zygosity, and 
age at onset of psoriasis in the index twin as covariates. In 
this analysis an increased hazard ratio (HR) in monozygotic 
(MZ) twins relative to dizygotic (DZ) twins would signal a 
genetic susceptibility to psoriasis. The regression analysis was 
performed in SPSS 16.0 (SPSS, Inc., Chicago, IL, USA). The 
cumulative hazard of psoriasis in twin pairs was calculated with 
the statistical software R assigning one twin randomly as the 
proband. We also examined the correlation between the ages 
at onset of psoriasis within twin pairs using bivariate survival 
analysis under several different models. Firstly, we calculated 
rank correlations (“normalized” Kendall’s tau) in age at onset 
using twin pairs where the ordering was unambiguous, as per 
Oakes (23). We used bootstrapping to estimate standard errors, 
and permuted zygosity labels to test for equality of MZ and DZ 
twin correlations. We compared these results with those from 
a gamma-frailty bivariate survival analysis (Clayton-Oakes-
Glidden model) using both the R mets and parfm packages 
(24, 25).
RESULTS
Descriptive analysis of the cohort
In total, 34,781 subjects participated in the question-
naire study. Of these, 97% (33,588) had complete data 
on psoriasis. A total of 12,927 subjects were from the 
cohort born in 1931–1952, and a total of 20,661 subjects 
were from the cohort born in 1953–1982. The zygosity 
was identified in 32,651 subjects. Of these 21,450 twin 
individuals had complete data on psoriasis and belonged 
to an intact twin pair (10,725 pairs in total); 3,246 mo-
nozygotic (MZ) twin pairs and 7,479 dizygotic (DZ) 
twin pairs (4,010 same sex and 3,469 opposite sex). 
Psoriasis was present in 1,401 twins. Of these, 896 
subjects (64%) also reported their age at onset; 68% of 
the women and 58% of the men. The non-responders 
were, on average, older than responders (49.1 vs. 45.7 
years). The mean age of the population was 44.5 years 
and the prevalence of psoriasis was 4.2%.
Age at onset of psoriasis in the whole sample
Among subjects with psoriasis, the median age at onset 
was 25 years among women and 28 years among men. 
The distribution of age at onset of psoriasis defined 
2 age-related groups: a major group with peak age 
at onset in the mid-20s (lowest among women), and 
a smaller late-onset group with a peak age at onset 
around 50 years (lowest among men) (Fig. 1). A total 
of 80% of women and 76% of men had early onset of 
psoriasis (≤ 40 years of age), whereas before or at the 
age of 30 years 65% of women and 58% of men had 
developed psoriasis.
Age at onset of psoriasis within twin pairs
Of 820 twin pairs with complete information on age 
at onset, a total of 99 pairs (45 MZ, 30 DZ same sex, 
and 24 DZ opposite sex pairs) were concordant for 
psoriasis, whereas 721 (179 MZ, 270 DZ same sex, 
and 272 DZ opposite sex pairs) were discordant.
Fig. 2 shows the risk of psoriasis in the co-twin of an 
affected twin for MZ and DZ same sex twins separately, 
as a function of age at onset in the index twin. After 
adjustment for age at onset of psoriasis in the index 
twin, the risk of psoriasis was increased in MZ co-
twins relative to DZ co-twins, HR = 2.16 (1.37–3.40), 
p < 0.001. The risk of psoriasis in the co-twin was not 
significantly related to age at onset of psoriasis in the 
index twin, HR (per year of later onset) = 1.01 (0.99–
1.03), p = 0.434, indicating that familial aggregation of 
psoriasis is uniform across ages.
The estimated rank correlations (Kendall tau) in the 
ages at onset of psoriasis within twin pairs was 0.84 
(bootstrap SE = 0.044) in MZ twin pairs and 0.60 (0.051) 
in DZ twin pairs, permutation p for difference between 
MZ and DZ twins p = 0.001. MZ 
female and male pairs did not 
differ significantly in within-pair 
correlation from one another, as 
was also the case for DZ pairs. 
On dividing the pairs into current 
age below or above 40 years, the 
DZ correlation in age at onset was 
significantly higher for older than 
for younger twins (tau 0.68 vs. 
0.29, permutation p = 0.01), but 
in the smaller MZ sample did not 
reach significance. We also dicho-
tomized age at onset into prior to 
20 years old vs. later, and defined 
the index twin as the earliest af-
fected. If the index twin had an 
onset before 20 years, a late onset 
in the co-twin was seen in only 9 Fig. 1. Distribution of age at onset of psoriasis among women and men in the whole sample.
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of 589 pairs; if the index twin onset was after 20 years, 
161 of 348 co-twins had been diagnosed with psoriasis.
DISCUSSION
The main conclusions of this study are: (i) overall, 
women have an earlier age at onset of psoriasis than 
men; however, there is a bimodal age-distribution of 
onset of psoriasis, with a primary peak at around 20 
years of age (lowest among women), and a second 
peak at around 50 years of age (lowest among men); 
(ii) the age at onset of psoriasis is significantly more 
correlated among MZ twin pairs than among DZ twin 
pairs, consistent with genetic factors explaining part of 
the variation in the age at onset of the disease; and (iii) 
there is no consistent evidence to support the hypothe-
sis that early-onset psoriasis is more familial (genetic) 
than late-onset psoriasis exemplified by the observation 
that earlier onset of psoriasis in the index twin did not 
predict a higher risk of psoriasis in the co-twin.
A median age at onset of psoriasis of 25 years among 
women and 28 years among men is comparable with 
previous studies (12, 13, 15, 17, 26–28). Some studies 
have examined a young population, which gives a low 
age at onset of psoriasis (14, 16). The age of the subjects 
at the time of examination differs between previous 
studies. In our study the subjects were 20–71 years old. 
Studies of subjects with an older age at examination can 
be expected to find a more accurate mean age at onset (12, 
13); however, these studies are more susceptible to recall 
bias. The younger age at onset in females compared with 
males is compatible with findings from earlier studies 
and has been attributed partly to puberty (5, 14, 16, 26).
Our data suggest 2 age-related peaks in psoriasis-onset. 
Similar peaks have been found in previous studies and 
this has given rise to the hypothesis that 2 forms of pso-
riasis exist: early-onset psoriasis, which is more severe 
and inherited (type 1); whereas late-onset psoriasis is 
less severe and sporadic (type 2). In contrast to our study, 
which is population-based, most prior studies are based 
on physician-diagnosed samples. Most previous studies 
are therefore selected and not random, which increases 
the risk of ascertainment and referral bias and an overes-
timate of the heritability of early-onset psoriasis, since 
such studies are more prone to selecting severe cases of 
the disease. A study by Melski & Stern from the USA 
(29) found that early-onset psoriasis is more heritable and 
that age at onset aggregates within families; however, 
they found no association of age at onset with severity, 
but their population was composed of patients with 
severe psoriasis. Specific genes have previously been 
found to be associated with early-onset psoriasis (5, 10, 
11, 30). Genome-wide association studies of psoriasis 
have focused primarily on early-onset psoriasis and have 
identified a total of 36 loci associated with psoriasis (31). 
Hébert et al. (32) investigated the genetic susceptibility 
to late-onset psoriasis and found a genetic overlap with 
early-onset psoriasis, but also found loci that were exclu-
sively associated with late-onset psoriasis. This explains 
and supports the finding that age at onset is an inherited 
property. Swanbeck et al. (33) from Sweden advocate 3 
distinct groups of patients with respect to age at onset, 
and that age at onset is an inherited character. Ejaz et 
al. (28) studied a population from Pakistan and found 
no significant differences in severity and family history 
between 2 age-related groups when assigning early-onset 
psoriasis to occur before the age of 30 years.
Based on the observed distribution of age at onset of 
psoriasis we assigned early-onset to occur before or at 
the age of 40 years to make sure the first peak was in 
this group. This definition of the groups is consistent 
with prior studies; however, some studies have set 
early-onset psoriasis to occur before 30 years, which 
makes it more difficult to compare results. In our data-
set 80% of women and 76% of men had early-onset 
psoriasis, which is congruent with earlier studies of 
large populations (Table SI1).
The rank correlation between ages at onset of pso-
riasis was 0.84 and 0.60 in MZ twins and DZ twins, 
respectively, consistent with the hypothesis that genetic 
factors explain part of the variation in the age at onset. 
Duffy et al. (17) found almost a perfect linear regression 
when plotting the ages at onset of psoriasis in concor-
dant MZ twins. Swanbeck et al. (9) investigated families 
with 1 proband and 2 affected siblings, and estimated 
the correlation between the age at onset in the proband 
and the first sibling to be 0.40, and between the 2 affec-
ted siblings to be 0.42. Differences in MZ twins might 
be due to unmeasured epigenetic factors rather than the 
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Fig. 2. Risk of developing psoriasis in the co-twin of an affected twin, as a 
function of age at onset in the index twin. Monozygotic (MZ) and dizygotic 
(DZ) same sex twins are illustrated separately.
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environment alone. However, epigenetics might also 
be an inherited factor and could thereby influence the 
genetic component (34).
We diagnosed psoriasis and its age at onset based on 
answers to a questionnaire with a resulting risk of false-
positive and false-negative answers, and also of recall-
bias. However, diagnostic validation of psoriasis in our 
sample confirmed the diagnosis in 89–100% of the twins 
(15). The Danish Twin Registry is among the largest and 
most comprehensive twin registries in the world. The 
results of this study are therefore of unique significance.
We conclude that the age at onset of psoriasis is partly 
an inherited property exemplified by the observation that 
age at onset of the disease is more correlated in MZ than 
in DZ twins. We did not confirm previous studies’ reports 
that early-onset psoriasis is more genetically determined 
than late-onset psoriasis. Finally, women have an earlier 
age at onset of psoriasis than men. The age distribution 
curve is bimodal, with a primary peak at around 20 years 
of age and a second peak at around 50 years of age.
The authors declare no conflicts of interest.
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